vs
Acadia Healthcare Company, Inc.（ACHC）与SCANSOURCE, INC.（SCSC）财务数据对比。点击上方公司名可切换其他公司
Acadia Healthcare Company, Inc.的季度营收约是SCANSOURCE, INC.的1.1倍（$829.0M vs $766.5M），SCANSOURCE, INC.净利率更高（2.2% vs 0.5%，领先1.6%），Acadia Healthcare Company, Inc.同比增速更快（7.5% vs 2.5%），过去两年Acadia Healthcare Company, Inc.的营收复合增速更高（2.0% vs 0.9%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
ScanSource是全球领先的专业技术分销商，主营销售点系统、条码扫描设备、网络安全产品、云服务及通信解决方案，面向北美、拉美、欧洲的增值经销商、服务提供商及企业客户，覆盖零售、医疗、工业、公共部门等领域。
ACHC vs SCSC — 直观对比
营收规模更大
ACHC
是对方的1.1倍
$766.5M
营收增速更快
ACHC
高出5.0%
2.5%
净利率更高
SCSC
高出1.6%
0.5%
两年增速更快
ACHC
近两年复合增速
0.9%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $829.0M | $766.5M |
| 净利润 | $4.5M | $16.5M |
| 毛利率 | — | 13.4% |
| 营业利润率 | — | 2.3% |
| 净利率 | 0.5% | 2.2% |
| 营收同比 | 7.5% | 2.5% |
| 净利润同比 | -50.8% | -3.3% |
| 每股收益（稀释后） | $0.05 | $0.75 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCSCSC
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $766.5M | ||
| Q3 25 | $851.6M | $739.6M | ||
| Q2 25 | $869.2M | $812.9M | ||
| Q1 25 | $770.5M | $704.8M | ||
| Q4 24 | $774.2M | $747.5M | ||
| Q3 24 | $815.6M | $775.6M | ||
| Q2 24 | $796.0M | $746.1M |
净利润ACHCSCSC
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $16.5M | ||
| Q3 25 | $36.2M | $19.9M | ||
| Q2 25 | $30.1M | $20.1M | ||
| Q1 25 | $8.4M | $17.4M | ||
| Q4 24 | $32.6M | $17.1M | ||
| Q3 24 | $68.1M | $17.0M | ||
| Q2 24 | $78.5M | $16.1M |
毛利率ACHCSCSC
| Q1 26 | — | — | ||
| Q4 25 | — | 13.4% | ||
| Q3 25 | — | 14.5% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | — | 14.2% | ||
| Q4 24 | — | 13.6% | ||
| Q3 24 | — | 13.1% | ||
| Q2 24 | — | 13.0% |
营业利润率ACHCSCSC
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 2.3% | ||
| Q3 25 | 4.7% | 3.5% | ||
| Q2 25 | 5.8% | 3.3% | ||
| Q1 25 | 1.7% | 3.2% | ||
| Q4 24 | 4.9% | 2.5% | ||
| Q3 24 | 12.1% | 2.3% | ||
| Q2 24 | 13.4% | 2.9% |
净利率ACHCSCSC
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 2.2% | ||
| Q3 25 | 4.3% | 2.7% | ||
| Q2 25 | 3.5% | 2.5% | ||
| Q1 25 | 1.1% | 2.5% | ||
| Q4 24 | 4.2% | 2.3% | ||
| Q3 24 | 8.4% | 2.2% | ||
| Q2 24 | 9.9% | 2.2% |
每股收益（稀释后）ACHCSCSC
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $0.75 | ||
| Q3 25 | $0.40 | $0.89 | ||
| Q2 25 | $0.33 | $0.87 | ||
| Q1 25 | $0.09 | $0.74 | ||
| Q4 24 | $0.36 | $0.70 | ||
| Q3 24 | $0.74 | $0.69 | ||
| Q2 24 | $0.85 | $0.66 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $158.5M | $83.5M |
| 总债务越低越好 | $2.5B | — |
| 股东权益账面价值 | $2.0B | $910.9M |
| 总资产 | $5.5B | $1.7B |
| 负债/权益比越低杠杆越低 | 1.29× | — |
8季度趋势，按日历期对齐
现金及短期投资ACHCSCSC
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $83.5M | ||
| Q3 25 | $118.7M | $124.9M | ||
| Q2 25 | $131.4M | $126.2M | ||
| Q1 25 | $91.2M | $146.3M | ||
| Q4 24 | $76.3M | $110.5M | ||
| Q3 24 | $82.1M | $145.0M | ||
| Q2 24 | $77.2M | $185.5M |
总债务ACHCSCSC
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — |
股东权益ACHCSCSC
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $910.9M | ||
| Q3 25 | $3.1B | $914.0M | ||
| Q2 25 | $3.1B | $906.4M | ||
| Q1 25 | $3.0B | $901.7M | ||
| Q4 24 | $3.1B | $900.7M | ||
| Q3 24 | $3.0B | $920.9M | ||
| Q2 24 | $3.0B | $924.3M |
总资产ACHCSCSC
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $1.7B | ||
| Q3 25 | $6.4B | $1.7B | ||
| Q2 25 | $6.3B | $1.8B | ||
| Q1 25 | $6.1B | $1.7B | ||
| Q4 24 | $6.0B | $1.7B | ||
| Q3 24 | $5.9B | $1.8B | ||
| Q2 24 | $5.7B | $1.8B |
负债/权益比ACHCSCSC
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $61.5M | $30.8M |
| 自由现金流经营现金流 - 资本支出 | — | $28.9M |
| 自由现金流率自由现金流/营收 | — | 3.8% |
| 资本支出强度资本支出/营收 | — | 0.3% |
| 现金转化率经营现金流/净利润 | 13.78× | 1.87× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ACHCSCSC
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $30.8M | ||
| Q3 25 | $73.2M | $23.2M | ||
| Q2 25 | $133.5M | — | ||
| Q1 25 | $11.5M | $66.1M | ||
| Q4 24 | $116.7M | $-6.2M | ||
| Q3 24 | $163.1M | $44.8M | ||
| Q2 24 | $171.1M | — |
自由现金流ACHCSCSC
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $28.9M | ||
| Q3 25 | $-63.0M | $20.8M | ||
| Q2 25 | $-34.2M | — | ||
| Q1 25 | $-163.2M | $64.6M | ||
| Q4 24 | $-86.8M | $-8.2M | ||
| Q3 24 | $-27.1M | $42.5M | ||
| Q2 24 | $16.9M | — |
自由现金流率ACHCSCSC
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 3.8% | ||
| Q3 25 | -7.4% | 2.8% | ||
| Q2 25 | -3.9% | — | ||
| Q1 25 | -21.2% | 9.2% | ||
| Q4 24 | -11.2% | -1.1% | ||
| Q3 24 | -3.3% | 5.5% | ||
| Q2 24 | 2.1% | — |
资本支出强度ACHCSCSC
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 0.3% | ||
| Q3 25 | 16.0% | 0.3% | ||
| Q2 25 | 19.3% | 0.3% | ||
| Q1 25 | 22.7% | 0.2% | ||
| Q4 24 | 26.3% | 0.3% | ||
| Q3 24 | 23.3% | 0.3% | ||
| Q2 24 | 19.4% | 0.2% |
现金转化率ACHCSCSC
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 1.87× | ||
| Q3 25 | 2.02× | 1.17× | ||
| Q2 25 | 4.43× | — | ||
| Q1 25 | 1.37× | 3.79× | ||
| Q4 24 | 3.58× | -0.36× | ||
| Q3 24 | 2.39× | 2.64× | ||
| Q2 24 | 2.18× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
SCSC
| Products And Services | $723.4M | 94% |
| Intelisys Advisory | $25.0M | 3% |
| Recurring Revenue | $18.2M | 2% |
